Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?
Abstract Pancreatic cancer (PC) remains one of the deadliest malignancies worldwide. Chemoresistance is a significant clinical problem in pancreatic ductal adenocarcinoma (PDAC) and numerous potential mechanisms have been demonstrated but much remains to be understood. To overcome the existing limit...
Main Authors: | Wenhao Luo, Gang Yang, Jiangdong Qiu, Jingyang Luan, Ying Zhang, Lei You, Mengyu Feng, Fangyu Zhao, Yueze Liu, Zhe Cao, Lianfang Zheng, Taiping Zhang, Yupei Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-10-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2384 |
Similar Items
-
Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications
by: Jiangdong Qiu, et al.
Published: (2018-01-01) -
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
by: Yibo Fu, et al.
Published: (2021-02-01) -
Is Invagination Anastomosis More Effective in Reducing Clinically Relevant Pancreatic Fistula for Soft Pancreas After Pancreaticoduodenectomy Under Novel Fistula Criteria: A Systematic Review and Meta-Analysis
by: Zhe Cao, et al.
Published: (2020-08-01) -
Role of the microbiome in occurrence, development and treatment of pancreatic cancer
by: Yicheng Wang, et al.
Published: (2019-12-01) -
LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
by: Mengyu Feng, et al.
Published: (2018-11-01)